[{"Assets_0_Q3_USD":3285200000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":126484326.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":126799130.0,"StockholdersEquityConverted_0_Q3_USD":642700000.0,"StockholdersEquity_0_Q3_USD":642700000.0,"RevenuesConverted_3_Q3_USD":1458500000.0,"RevenuesConverted_1_Q3_USD":532600000.0,"NetIncomeLossConverted_3_Q3_USD":48000000.0,"NetIncomeLossConverted_1_Q3_USD":26000000.0,"NetCashProvidedByUsedInOperatingActivitiesConverted_3_Q3_USD":199300000.0,"EarningsPerShareDiluted_3_Q3_USD":0.38,"EarningsPerShareDiluted_1_Q3_USD":0.21,"EarningsPerShareBasic_3_Q3_USD":0.38,"EarningsPerShareBasic_1_Q3_USD":0.21,"CommonStockSharesOutstanding_0_Q3_shares":124927160.0,"CommonStockSharesConverted_0_Q3_shares":124927160.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":124951928.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":124897130.0,"Ticker":"CTLT","CIK":"1596783","name":"CATALENT, INC.","OfficialName":"Catalent Inc. Common Stock","form":"10-Q","period":"20170331","fy":"2017.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"17076283108.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","SP500":"SP500","filed":"20170504"}]